.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Novartis
US Army
Fuji
Medtronic
Argus Health
Colorcon
Healthtrust
Cantor Fitzgerald
Cipla

Generated: June 27, 2017

DrugPatentWatch Database Preview

Paromomycin sulfate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for paromomycin sulfate and what is the scope of paromomycin sulfate patent protection?

Paromomycin sulfate
is the generic ingredient in two branded drugs marketed by King Pfizer, Parkedale, Parke Davis, Sun Pharm Inds Inc, and Heritage Pharms Inc, and is included in five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for paromomycin sulfate. Three suppliers are listed for this compound.

Summary for Generic Name: paromomycin sulfate

Tradenames:2
Patents:1
Applicants:5
NDAs:5
Drug Master File Entries: see list1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list65
Clinical Trials: see list664
Patent Applications: see list1,291
Therapeutic Class:Antibacterials
Drug Prices:see low prices
DailyMed Link:paromomycin sulfate at DailyMed

Pharmacology for Ingredient: paromomycin sulfate

Drug ClassAntiprotozoal
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parkedale
HUMATIN
paromomycin sulfate
CAPSULE;ORAL060521-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Heritage Pharms Inc
PAROMOMYCIN SULFATE
paromomycin sulfate
CAPSULE;ORAL065173-001Dec 14, 2007AARXNoNo► Subscribe► Subscribe
King Pfizer
HUMATIN
paromomycin sulfate
CAPSULE;ORAL062310-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sun Pharm Inds Inc
PAROMOMYCIN SULFATE
paromomycin sulfate
CAPSULE;ORAL064171-001Jun 30, 1997AARXNoYes► Subscribe► Subscribe
Parke Davis
HUMATIN
paromomycin sulfate
SYRUP;ORAL060522-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
QuintilesIMS
Cipla
Boehringer Ingelheim
Baxter
Fish and Richardson
Daiichi Sankyo
US Army
Dow
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot